Skip to main content

and
  1. Article

    Open Access

    Exercise training in pulmonary arterial hypertension associated with connective tissue diseases

    The objective of this prospective study was to assess short- and long-term efficacy of exercise training (ET) as add-on to medical therapy in patients with connective tissue disease-associated pulmonary arteri...

    Ekkehard Grünig, Felicitas Maier, Nicola Ehlken in Arthritis Research & Therapy (2012)

  2. Article

    Open Access

    Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study

    Patients with mean pulmonary artery pressures (mPAP) of 21 to 24 mm Hg have a so-called borderline elevation of mPAP (BoPAP)—a condition thought to represent early-stage pulmonary arterial vasculopathy. Based ...

    Scott H Visovatti, Oliver Distler, J Gerry Coghlan in Arthritis Research & Therapy (2014)

  3. Article

    Open Access

    Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension

    In patients with systemic sclerosis (SSc), associated pulmonary arterial hypertension (SSc-APAH) is the leading cause of death. The objective of this prospective screening study was to analyse sensitivity and ...

    Christian Nagel, Philipp Henn, Nicola Ehlken in Arthritis Research & Therapy (2015)

  4. No Access

    Article

    Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study

    Enlargement and dysfunction of the right atrium might be an early sign for pulmonary hypertension in systemic sclerosis (SSc). This is the first study to analyse right atrial morphology and function in SSc pat...

    Antonello D’Andrea, Michele D’Alto, Marco Di Maio, Serena Vettori in Clinical Rheumatology (2016)

  5. Article

    Open Access

    Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)

    The objective of this randomized, placebo-controlled, double-blind, parallel group, trial was to assess the effect of ambrisentan on mean pulmonary arterial pressure (mPAP) in patients with systemic sclerosis ...

    Zixuan Pan, Alberto M. Marra, Nicola Benjamin in Arthritis Research & Therapy (2019)

  6. Article

    Open Access

    Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis

    The objective of this study was to investigate the prognostic impact of right ventricular (RV) function at rest and during exercise in patients with systemic sclerosis (SSc) presenting for a screening for pulm...

    Panagiota Xanthouli, Julia Miazgowski, Nicola Benjamin in Arthritis Research & Therapy (2022)

  7. Article

    Open Access

    Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension

    Patients with systemic sclerosis (SSc) are frequently affected by iron deficiency, particularly those with pulmonary hypertension (PH). The first data indicate the prognostic importance of hypochromic red cell...

    Panagiota Xanthouli, Ojan Gordjani, Nicola Benjamin in Arthritis Research & Therapy (2023)

  8. Article

    Open Access

    Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

    In the event-driven FREEDOM-EV trial, oral treprostinil delayed clinical worsening in patients with pulmonary arterial hypertension (PAH). Open-label extension studies offer additional data about tolerability,...

    Ekkehard Grünig, Franck Rahaghi, Jean Elwing, Carmine Dario Vizza in Advances in Therapy (2024)